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Background: Plasminogen deficiency is a rare autosomal recessive disease, which is associated with aggressive
periodontitis and gingival enlargement. Previously described treatments of plasminogen deficiency associated
periodontitis have shown limited success. This is the first case report indicating a successful therapy approach
consisting of a non-surgical supra- and subgingival debridement in combination with an adjunctive systemic
antibiotic therapy and a strict supportive periodontal regimen over an observation period of 4 years.
Case presentation: The intraoral examination of a 17-year-old Turkish female with severe plasminogen
deficiency revealed generalized increased pocket probing depths ranging from 6 to 9 mm, bleeding on
probing over 30%, generalized tooth mobility, and gingival hyperplasia. Alveolar bone loss ranged from 30% to
50%. Clinical attachment loss corresponded to pocket probing depths. Aggregatibacter actinomycetemcomitans,
Porphyromonas gingivalis, Treponema denticola, Prevotella intermedia, Prevotella nigrescens and Eikenella corrodens
have been detected by realtime polymerase chain reaction. Periodontal treatment consisted of full mouth
disinfection and adjunctive systemic administration of amoxicillin (500 mg tid) and metronidazole (400 mg tid).
A strict supportive periodontal therapy regimen every three month in terms of supra- and subgingival debridement
was rendered. The reported therapy has significantly improved periodontal health and arrested disease progression.
Intraoral examination at the end of the observation period 3.5 years after non-surgical periodontal therapy showed
generalized decreased pocket probing depths ranging from 1 to 6 mm, bleeding on probing lower 30%, and tooth
mobility class I and II.
Furthermore, microbiological analysis shows the absence of Porphyromonas gingivalis, Prevotella intermedia and
Treponema denticola after therapy.
Conclusion: Adjunctive antibiotic treatment may alter the oral microbiome and thus, the inflammatory response of
periodontal disease associated to plasminogen deficiency and diminishes the risk of pseudomembrane formation and
progressive attachment loss.
This case report indicates that patients with plasminogen deficiency may benefit from non-surgical periodontal
treatment in combination with an adjunctive antibiotic therapy and a strict supportive periodontal therapy regimen.
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Figure 1 Panoramic radiograph at the age of 9 years: exhibiting signs of untreated periodontal disease.
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Plasminogen (PLG) is the proenzyme of plasmin and pre-
dominately synthesized by the liver. Although the role of
plasmin in intra- and extravascular fibrinolysis is well
defined, it also acts as a broad spectrum proteolytic factor
either by directly degrading extracellular matrix proteins,
e.g. laminin, fibronection and proteoglycans, and indirectly
by activating latent metalloproteinases [1,2]. Thus, it ex-
erts crucial functions in tissue homeostasis, e.g. remodel-
ing, angiogenesis, and wound healing [3-5]. Moreover,
plasmin has also been found to play an important role in
host defense against infections [1].
Plasminogen deficiency is a rare (1.6 in 1 million indi-
viduals) autosomal recessive disease caused by homozygote
or compound-heterozygote mutations of the plasminogen
gene PLG 6q26. There are two types of plasminogen defi-
ciency: hypoplasminogenemia (type I PLG deficiency), inFigure 2 Panoramic radiograph at the age of 13 years: no periodontal thewhich level and activity of PLG are reduced and dysplasmi-
nogenemia (type II PLG deficiency), in which the level of
immunoreactive PLG is within normal range, but the spe-
cific activity of PLG is reduced [6-9].
Clinical symptoms of type I PLG deficiency include
recurrent, wood like (ligneous) pseudomembranes on
mucosal surfaces of the eyes (87% of cases), upper and
lower respiratory tract (33%), vagina (19%), and gastro-
intestinal tract (3%) [9]. In addition, approximately one
third of the affected individuals suffer from pseudomem-
branes of the oral cavity [7,10,11].
Ligneous periodontitis is characterized by gingival
enlargement and severe attachment loss, which is associ-
ated with the accumulation of amyloid-like material in
the lamina propria [2]. Treatment approaches for peri-
odontitis associated with PLG deficiency included surgi-
cal and non-surgical periodontal therapy. Periodontalrapy was rendered since the age of 9.
Figure 3 Florida Probe periodontal chart at Baseline: Periodontal measurement before full-mouth supra- and subgingival debridement in combination
with an adjunctive antibiotic therapy.
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ment appeared initially promising, but eventually resulted
in pseudomembrane regrowth. Periodontal non-surgical
treatment alone i.e. without periodontal surgery or in com-
bination with chlorhexidine mouth rinses, topical adminis-
tration of plasminogen or heparin, or administration ofsystemic antibiotics, have been described. However, these
treatments have failed to arrest periodontal disease pro-
gression in subjects with type I PLG deficiency [8,12,2].
The present case report presents the treatment of a fe-
male patient with a severe, generalized periodontitis modi-
fied by systemic factors (type I PLG deficiency) using a
Figure 4 Panoramic radiograph at the age of 16 years: three years following conventional quadrantwise supra- and subgingival debridement
without any supportive periodontal therapy.
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cific adjunctive systemic antibiotic therapy aimed at alter-
ing the oral microbiome.Case presentation
The presented patient is a Turkish female diagnosed
with type I PLG deficiency (plasminogen activity of 2%).
Both of her siblings had also been diagnosed with type I
PLG deficiency. At the age of 9 years, the patient pre-
sented with conjunctivitis lignosa at the Department of
Pediatrics, University of Duesseldorf, where additional
ligneous lesions at the mucosa of the middle ear, respira-
tory tract, vagina, and gingival hyperplasia were found.Figure 5 Intraoral photographs at the age of 16 years: three years followin
without any supportive periodontal therapy.The intraoral examination at the Department of Peri-
odontics, University of Duesseldorf revealed erythema-
tous and hyperplastic gingiva in the upper and lower jaw
and Class 3 mobility of all of the deciduous teeth [13].
The panoramic radiograph showed severe generalized al-
veolar bone loss (Figure 1). The histological assessment
of a gingival biopsy was taken buccaly from the second
milk molar in the right lower jaw and showed a reactive
squamous epithelial hyperplasia with localized fibrin pre-
cipitation and massive ulcerations. As the patient did
not present for the follow-up appointments, no peri-
odontal therapy was rendered at the time.
When she was 13 years old, the patient presented
again for periodontal evaluation. At the time, the patientg conventional quadrantwise supra- and subgingival debridement
Figure 6 Florida Probe periodontal chart at the time of reevaluation: Six weeks after full-mouth supra- and subgingival debridement in combination
with an adjunctive antibiotic therapy.
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with mycophenolat-mophetil for the management of a
severe pneumonia and hematocolpos. In addition, she
was receiving longterm antibiotic therapy with ciproflox-
acin and pyrazinomid for a pulmonary infection with
multiresistant tuberculosis bacteria. The periodontalevaluation revealed signs of generalized severe periodon-
titis with gingival hyperplasia, ulceration and fibrinous
pseudomembranes. The panoramic radiograph showed
generalized horizontal bone loss of 10% to 30% at the
upper and lower anterior teeth and vertical alveolar bone
loss at all first molars (Figure 2). Four quadrant supra-
Figure 7 Florida Probe periodontal chart supportive periodontal therapy: 12 months following non-surgical periodontal therapy.
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tient did not return for supportive periodontal therapy.
At the age of 16 years the patient returned. The clinical
examination revealed generalized increased tooth mobility
and gingival hyperplasia (Figure 3). The patient com-
plained about severe halitosis and impaired aesthetics due
to the gingival hyperplasia. Compared to the clinical andradiological assessment at 13 years of age, a progression of
attachment and bone loss was noted (Figures 4 and 5). A
microbiological analysis of supra- and subgingival plaque
[14] revealed the intraoral presence of Porphyromonas
gingivalis, Eikenella corrodens, Prevotella intermedia, Pre-
votella nigrescens, Tannerella forsythensis, and Treponema
denticola. Aggregatibacter actinomycetemcomitans was not
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plaque before non-surgical periodontal therapy was
taken from the deepest periodontal pocket in each sex-
tant and microbial species were detected by polymerase
chain reaction (PCR).
The supra- and subgingival debridement of all teeth
was performed under local anesthesia within 24 hours
and maxillary right and both mandibulary first molars
were extracted. The patient was given oral hygiene in-
struction. Adjunctive antimicrobial therapy included sys-
temic administration of amoxicillin (500 mg tid) and
metronidazole (400 mg tid) and twice daily rinsing with
0.2% chlorhexidin digluconate for two weeks [15-17].
Eight weeks following the treatment the gingival hyperpla-
sia, pocket probing depth and bleeding on probing were
markedly reduced (Figure 6). The patient received sup-
portive periodontal therapy every three months (Figure 7).
At a follow-up examination at the age of 18 years, there
were only minimal signs of residual gingival hyperplasia
(regio 32–42) and signs of arrested periodontitis (Figures 8
and 9). A microbiological analysis showed the intraoral ab-
sence of Aggregatibacter actinomycetemcomitans, Porphyr-
omonas gingivalis, Prevotella intermedia and Treponema
denticola. Interestingly, the clinical signs of type I PLG de-
ficiency at the ear, urogenital tract and upper respiratory
tract and the eyes showed positive changes at the same
time following periodontal therapy. The situation proved
to be stable since (Figure 10) and at the age of 19 it was de-
cided to improve estethics in the upper anterior region by
direct restaurations with composite (Filtek Supreme XTE,
3 M Espe, Seefeld, Germany). In the lower anterior regionFigure 8 Intraoral photographs at the age of 18 years: two years following
an adjunctive antibiotic therapy and supportive periodontal therapy everydirect composite restaurations (Filtek Supreme XTE, 3 M
Espe, Seefeld, Germany) in combination with glas fiber
(Ribbond THM, Ribbond, Seattle, USA) reinforced com-
posite pontics were used (Figures 11, 12 and 13).
Discussion
The clinical signs of ligneous periodontitis are character-
ized by an aggressive periodontal tissue destruction and
loss of alveolar bone and teeth. The exact pathophysiology
of ligneous periodontitis remains, however, unclear [18,1].
In vitro data and animal studies indicated that alterations
in tissue repair and host defense mechanisms are respon-
sible for the onset and the progression of periodontal de-
struction [1,19]. Local extracellular fibrinolysis by plasmin
is required for the initial removal of the fibrin-rich matrix
as well as for the remodeling of the granulation tissue and
completion of wound healing [9,20,5]. Impairment of the
pathway due to hypoplasminogenemia leads to fibrin ac-
cumulation and an increased inflammatory reaction. Con-
sequently, the process of wound healing stops at the stage
of granulation tissue formation and cellular proteolysis,
which may then further support the invasion of pathogens.
This process is notably pronounced in mucous mem-
branes such as the periodontal tissues [12,20]. The fact
that only 32% of patients who suffer from PLG type I defi-
ciency develop ligneous periodontitis strongly supports
the notion that external triggers, i.e. trauma or infection
may play an additional significant role in the pathogenesis
of this disease [21,10,9,22,11,2]. Therefore, the reduction
of the bacterial load by an adjunctive systemic antibiotic
therapy seems to be a reasonable therapy strategy tofull mouth supra- and subgingival debridement in combination with
3 months.
Figure 9 Florida Probe periodontal chart at the age of 18 years: Periodontal supportive therapy two years following full mouth supra- and
subgingival debridement in combination with an adjunctive antibiotic therapy and supportive periodontal therapy every 3 months.
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sion of the disease. It is well known that biofilm bacteria
show much greater resistance to antibiotics than their
free-living counterparts. One potential reason for this in-
creased resistance is the penetration barrier that biofilmspresent to antimicrobials. A complete disruption of the
intraoral biofilm within a short period of time is there-
fore a prerequisite for the best possible antibiotic effi-
cacy. For that reason the applied therapy approach
followed the concept of full-mouth disinfection, i.e. a
Figure 10 Florida Probe periodontal chart at the end of observation period: 3.5 years following full- mouth supra- and subgingival debridement
in combination with an adjunctive antibiotic therapy and supportive periodontal therapy every 3 months.
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24 hours, followed by the adjunctive systemic antibiotic
therapy. In addition to that, the full mouth disinfection
approach has been shown to drastically reduce peri-
odontal pathogens in patients with generalized aggres-
sive periodontitis [23], thus potentially further reducingthe risk of disease progression. The presented treat-
ment strategy is further supported by the guidelines of
the American Academy of Periodontics as well as the
German Society for Periodontology that recommend
the use of a systemic adjunctive antibiotic therapy in
patients with aggressive periodontitis [16,24].
Figure 11 Intraoral photographs at the age of 19 years: three years following full mouth supra- and subgingival debridement in combination
with an adjunctive antibiotic therapy and supportive periodontal therapy every 3 months.
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ciency and oral lesions have been reported in the literature
[2]. Several therapeutic approaches have been described
[25-27,10,8,28] including scaling and root planning, chlor-
hexidine rinsing, administration of antibiotics [8,12] and
periodontal surgery. These case reports, however, lack de-
tailed information of the rendered dental therapy and the
intraoral colonization with periodontal pathogens. ThoseFigure 12 Intraoral photographs at the age of 19 years: 3.5. years following
an adjunctive antibiotic therapy and supportive periodontal therapy every
upper and lower anterior region. Note: photographs have been taken immvery few reports about the adjunctive use of antibiotics do
neither mention the type of antibiotic nor the duration of
its intake, and its association to any additional periodontal
treatment [29,26], thus precluding the validation of an ad-
junctive systemic antibiotic therapy. Most of the above
mentioned reports have been described as failures due to
rapid gingival regrowth and progressive bone loss [2].
Only Silva et al. report about a complete remission of thefull mouth supra- and subgingival debridement in combination with
3 months. Situation following direct restoration with composite in the
ediately following supportive periodontal therapy.
Figure 13 Panoramic radiograph at the age of 19 years: 3.5 years following full mouth supra- and subgingival debridement in combination with
an adjunctive antibiotic therapy and supportive periodontal therapy every 3 months.
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ically without gingivectomy [27]. However, the patient pre-
sented did not suffer from ligneous periodontitis, but from
gingival enlargement only. Another case report indicated
that the treatment with warfarin exerts protection against
relapsing gingival hyperplasia over an observation period
of 3 years in a 54 year old patient. The authors reported
about a combination of gingivectomy, an administration
of 20 mg doxycycline daily, and the use of a 0.12% chlor-
hexidine digluconate mouthrinse. One week after surgery
the patient started with 5 mg warfarin daily for an indefin-
ite time. Supportive periodontal therapy is not mentioned
[18]. Thus, it is not clear, which of the rendered treatment
or if their combination were responsible for the observed
clinical improvement. Moreover, the described patient
seemed to suffer from a clinically rather mild form of
ligneous periodontitis, had lost only few teeth, and was
considerably older (54 years) than other patients with lig-
neous periodontitis reported in the literature (average age
12–18 years). These differences may reflect variability in
PLG activity due to different plasminogen gene mutations.
Silva et al. [27] reported a complete regression of oral mu-
cous lesions after systemic and topical corticosteroids.
Data on the periodontal status and periodontal therapy
were not published, thus hampering the evaluation of
therapeutic effects on periodontal lesions.
A recent study in plasminogen-deficient mice demon-
strated massive periodontal breakdown paralleled by accu-
mulation of fibrin and neutrophils in affected periodontal
tissues [1]. Interestingly, the number of colony-forming
units in extracts prepared from homogenized mandibles
from PLG-deficient mice was found to be approximately
100-fold higher compared with wild-type mice. The
results indicate that bacterial invasion into periodontal
tissues is increased in PLG-deficient mice. This finding
strongly suggests that patients with PLG type I deficiency
might benefit from an adjunctive systemic antibiotictherapy. Only very few case reports describe a systemic
antibiotic treatment in PLG type I deficiency. However,
these case reports do neither mention the type of anti-
biotic used nor the duration and timing of its intake
[29,26] thus presenting no objective reason for the re-
ported failure of antibiotic therapy in PLG deficient
patients.Conclusions
In conclusion, we report on the first successful long-
term clinical management of a patient with PLG defi-
ciency type I.
This case report indicates that patients with PLG-
deficiency type I may benefit from non-surgical peri-
odontal therapy including full mouth disinfection in
combination with an adjunctive antibiotic therapy and a
strict supportive periodontal therapy regime every three
month.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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